CN113307848B - Cyclochrome-silk-valerian-isoleukin-leupeptide with antifungal and free radical scavenging activity and preparation method - Google Patents
Cyclochrome-silk-valerian-isoleukin-leupeptide with antifungal and free radical scavenging activity and preparation method Download PDFInfo
- Publication number
- CN113307848B CN113307848B CN202110602791.5A CN202110602791A CN113307848B CN 113307848 B CN113307848 B CN 113307848B CN 202110602791 A CN202110602791 A CN 202110602791A CN 113307848 B CN113307848 B CN 113307848B
- Authority
- CN
- China
- Prior art keywords
- culture
- liquid
- silk
- volume
- level
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000007760 free radical scavenging Effects 0.000 title claims abstract description 23
- 230000000843 anti-fungal effect Effects 0.000 title claims abstract description 17
- 229940121375 antifungal agent Drugs 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 238000000605 extraction Methods 0.000 claims abstract description 28
- 239000000843 powder Substances 0.000 claims abstract description 20
- 230000005764 inhibitory process Effects 0.000 claims abstract description 11
- -1 DPPH free radical Chemical class 0.000 claims abstract description 8
- 125000004122 cyclic group Chemical group 0.000 claims abstract description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims abstract description 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims abstract description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims abstract description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims abstract description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims abstract description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims abstract description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims abstract description 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims abstract description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims abstract description 3
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229960000310 isoleucine Drugs 0.000 claims abstract description 3
- 239000004474 valine Substances 0.000 claims abstract description 3
- 239000007788 liquid Substances 0.000 claims description 67
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 54
- 238000000855 fermentation Methods 0.000 claims description 50
- 230000004151 fermentation Effects 0.000 claims description 50
- 239000001963 growth medium Substances 0.000 claims description 42
- 239000000047 product Substances 0.000 claims description 42
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 34
- 230000001580 bacterial effect Effects 0.000 claims description 27
- 239000007787 solid Substances 0.000 claims description 23
- 238000009423 ventilation Methods 0.000 claims description 21
- 241000235579 Basidiobolus Species 0.000 claims description 18
- 239000000945 filler Substances 0.000 claims description 18
- 239000001103 potassium chloride Substances 0.000 claims description 18
- 235000011164 potassium chloride Nutrition 0.000 claims description 18
- 238000000746 purification Methods 0.000 claims description 18
- 230000000694 effects Effects 0.000 claims description 17
- 238000012807 shake-flask culturing Methods 0.000 claims description 16
- 241000194017 Streptococcus Species 0.000 claims description 15
- 150000003254 radicals Chemical class 0.000 claims description 15
- 241000894006 Bacteria Species 0.000 claims description 12
- 239000004480 active ingredient Substances 0.000 claims description 12
- 239000000284 extract Substances 0.000 claims description 12
- 239000002054 inoculum Substances 0.000 claims description 12
- 229920001817 Agar Polymers 0.000 claims description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 10
- 239000001888 Peptone Substances 0.000 claims description 10
- 108010080698 Peptones Proteins 0.000 claims description 10
- 239000008272 agar Substances 0.000 claims description 10
- 229940041514 candida albicans extract Drugs 0.000 claims description 10
- 239000008103 glucose Substances 0.000 claims description 10
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 claims description 10
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 claims description 10
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 10
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 10
- 235000019319 peptone Nutrition 0.000 claims description 10
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 10
- 230000002000 scavenging effect Effects 0.000 claims description 10
- 239000012138 yeast extract Substances 0.000 claims description 10
- 238000004366 reverse phase liquid chromatography Methods 0.000 claims description 9
- 238000000926 separation method Methods 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 238000009630 liquid culture Methods 0.000 claims description 7
- 239000012528 membrane Substances 0.000 claims description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- 230000005526 G1 to G0 transition Effects 0.000 claims description 6
- 244000061456 Solanum tuberosum Species 0.000 claims description 6
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 6
- 229910052799 carbon Inorganic materials 0.000 claims description 6
- 238000011097 chromatography purification Methods 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 6
- 238000010828 elution Methods 0.000 claims description 6
- 238000011081 inoculation Methods 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 238000011218 seed culture Methods 0.000 claims description 6
- 238000012549 training Methods 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 5
- 210000003608 fece Anatomy 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 239000002609 medium Substances 0.000 claims description 4
- 239000011343 solid material Substances 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 238000011049 filling Methods 0.000 claims description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 7
- 238000000034 method Methods 0.000 abstract description 7
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 4
- 230000003078 antioxidant effect Effects 0.000 abstract description 3
- 108010069514 Cyclic Peptides Proteins 0.000 abstract description 2
- 102000001189 Cyclic Peptides Human genes 0.000 abstract description 2
- 230000003712 anti-aging effect Effects 0.000 abstract description 2
- 239000003963 antioxidant agent Substances 0.000 abstract description 2
- 241000187759 Streptomyces albus Species 0.000 abstract 1
- 229940124350 antibacterial drug Drugs 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- 239000000126 substance Substances 0.000 description 8
- 241000233866 Fungi Species 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 238000005259 measurement Methods 0.000 description 5
- 239000000401 methanolic extract Substances 0.000 description 5
- 229940123457 Free radical scavenger Drugs 0.000 description 3
- 206010017533 Fungal infection Diseases 0.000 description 3
- 208000031888 Mycoses Diseases 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000002516 radical scavenger Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 244000126014 Valeriana officinalis Species 0.000 description 2
- 235000013832 Valeriana officinalis Nutrition 0.000 description 2
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 2
- 229960003942 amphotericin b Drugs 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 235000016788 valerian Nutrition 0.000 description 2
- 241000316922 Caldicoprobacter faecalis Species 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000000967 entomopathogenic effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002611 lead compounds Chemical class 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 244000039328 opportunistic pathogen Species 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/52—Cyclic peptides containing at least one abnormal peptide link with only normal peptide links in the ring
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Botany (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
技术领域Technical field
本发明属于生物制品的提取制备技术领域,涉及具有抗真菌和自由基清除活性的环色-丝-缬-异亮-亮肽(Trp-Ser-Val-Ile-Leu环肽)提取和纯化。The invention belongs to the technical field of extraction and preparation of biological products, and relates to the extraction and purification of cyclochrom-Ser-Val-Ile-Leu peptide (Trp-Ser-Val-Ile-Leu cyclic peptide) with antifungal and free radical scavenging activities.
背景技术Background technique
环色-丝-缬-异亮-亮肽是从一种蛙粪霉(Basidiobolussp. )培养物中分离制备得到的具有抗真菌和清除自由基活性的生物活性物质。Cyclochrome-silk-valerine-isoleutin-leuptide is a bioactive substance with antifungal and free radical scavenging activity isolated and prepared from a culture of Basidiobolus sp.
蛙粪霉(Basidiobolussp. )为虫霉目蛙粪霉科蛙粪霉属的真菌;在我国常见的有蛙生蛙粪霉、固孢蛙粪霉和裂孢蛙粪霉等。上述菌种可从土壤和两栖类动物粪便中分离得到。 Basidiobolus sp. is a fungus of the genus Basidiobolus in the order Basidiobolus, family Basidiobolus; the common ones in China include Basidiobolus sp., Basidiobolus sp., and Schizospermia sp. The above bacterial species can be isolated from soil and amphibian feces.
抗真菌活性:有多种真菌是条件致病菌,当人们抵抗力下降时容易感染,特别是老人和病人容易发生真菌感染。目前世界老龄化日趋严重,同时由于环境污染等因素,人们的抵抗力呈下降趋势,真菌感染病例呈上升趋势,同时早期抗真菌药已出现耐药现象,因此开发新型抗真菌活性物质非常有意义。Antifungal activity: There are many kinds of fungi that are opportunistic pathogens. People are prone to infection when their resistance is reduced, especially the elderly and patients are prone to fungal infection. At present, the world is aging increasingly. At the same time, due to factors such as environmental pollution, people's resistance is on a downward trend, fungal infection cases are on an upward trend, and resistance to early antifungal drugs has emerged. Therefore, it is very meaningful to develop new antifungal active substances. .
清除自由基活性:自由基(free radical),从化学结构上看是指含未配对电子的基团、原子或分子。自由基具有高度化学活性。对于生命体来说,自由基是生命活动中多种生化反应的中间产物。在正常情况下,人体内的自由基是处于产生与清除的动态平衡之中。自由基是机体有效的防御系统,如不能维持一定水平的自由基则会对机体生命活动带来不利影响。但自由基产生过多或清除过慢,它通过攻击生命大分子物质及各种细胞器,会造成机体分子水平、细胞水平及组织器官水平的各种损伤,加速机体的衰老进程并诱发各种疾病。最新的研究表明,人类的衰老及许多疾病都与自由基损伤有关。具有清除自由基活性的物质能与自由基反应并使之还原成非自由基化合物,可清除机体代谢过程中产生的过多的自由基,是一种可增进人体健康的重要活性物质。自由基清除剂在非生命体系中有抗氧化作用,能够有效地阻止物质的氧化败坏,对于延长物品的保质期有着重要作用,被广泛用于食品、药品、日用化学品等中。Free radical scavenging activity: Free radicals refer to groups, atoms or molecules containing unpaired electrons from a chemical structure perspective. Free radicals are highly chemically reactive. For living organisms, free radicals are intermediate products of various biochemical reactions in life activities. Under normal circumstances, free radicals in the human body are in a dynamic balance of production and elimination. Free radicals are an effective defense system of the body. Failure to maintain a certain level of free radicals will have adverse effects on the body's life activities. However, free radicals are produced too much or are cleared too slowly. By attacking macromolecules of life and various organelles, they can cause various damages at the molecular level, cellular level, and tissue and organ levels of the body, accelerate the aging process of the body, and induce various diseases. . The latest research shows that human aging and many diseases are related to free radical damage. Substances with free radical scavenging activity can react with free radicals and reduce them to non-free radical compounds. They can scavenge excessive free radicals produced during the metabolism of the body and are important active substances that can improve human health. Free radical scavengers have antioxidant effects in non-living systems, can effectively prevent the oxidative deterioration of substances, and play an important role in extending the shelf life of items. They are widely used in food, medicine, daily chemicals, etc.
发明内容Contents of the invention
本发明的目的是提供具有抗真菌和清除自由基活性的环色-丝-缬-异亮-亮肽及制备方法。The object of the present invention is to provide cyclochrome-silk-valerine-isoleutin-leutin peptide with antifungal and free radical scavenging activity and a preparation method thereof.
为寻找新型天然高效的具有抗真菌活性和清除自由基活性的物质,发明人通过对中国的100余株昆虫病原真菌代谢物进行活性研究,发现了从一种蛙粪霉中提取的环色-丝-缬-异亮-亮肽具有很强的抗白色链珠菌活性和清除自由基活性的作用。In order to find new natural and highly efficient substances with antifungal activity and free radical scavenging activity, the inventors conducted activity studies on the metabolites of more than 100 entomopathogenic fungi in China and discovered the cyclochrome- Silk-valerian-isoleutin-leupeptide has strong anti-Streptococcus albicans activity and free radical scavenging activity.
具有抗真菌和清除自由基活性的环色-丝-缬-异亮-亮肽的结构式如下:The structural formula of cyclochrome-silk-valerine-isoleukin-leuptide with antifungal and free radical scavenging activity is as follows:
所述环色-丝-缬-异亮-亮肽是由色氨酸、丝氨酸、缬氨酸、异亮氨酸和亮氨酸,以酰胺键连接而成的十五元环状五肽,为白色粉末状;The cyclochrome-silk-valerine-isoleucine-leuptide is a fifteen-membered cyclic pentapeptide composed of tryptophan, serine, valine, isoleucine and leucine connected by amide bonds. It is white powder;
所述环色-丝-缬-异亮-亮肽具有清除自由基活性和抗白色链珠菌活性;The cyclochrome-silk-valerian-isoleutin-leupeptide has free radical scavenging activity and anti-Streptococcus albicans activity;
对二苯基苦基苯肼自由基(DPPH)的半数清除浓度(DC50)为:1.19mg/mL,在200 μg/mL的浓度下对白色链珠菌的抑菌圈直径为13.27mm。The half scavenging concentration (DC 50 ) of p-diphenylpicrylphenylhydrazyl free radical (DPPH) is: 1.19mg/mL. At a concentration of 200 μg/mL, the diameter of the inhibition zone against Streptococcus albicans is 13.27mm.
具有抗真菌和清除自由基活性的环色-丝-缬-异亮-亮肽的制备操作步骤如下:The preparation steps of cyclochrome-silk-valerine-isoleutin-leuptide with antifungal and free radical scavenging activity are as follows:
(1)菌种培养(1) Bacterial culture
将蛙粪霉(Basidiobolussp.)经过斜面菌种培养、二级液体种子培养、三级液体种子培养和四级培养,得到液体的最终发酵物或固体的最终发酵物;Pass Basidiobolus sp. through slant culture, secondary liquid seed culture, third-level liquid seed culture and fourth-level culture to obtain a liquid final fermentation product or a solid final fermentation product;
(2)最终发酵物中有效成分的提取和精制(2) Extraction and purification of active ingredients in the final fermentation product
用甲醇或乙醇提取最终发酵物中的有效成分,采用反相色谱方法纯化,得到白色粉末状的环色-丝-缬-异亮-亮肽。The active ingredients in the final fermentation product are extracted with methanol or ethanol, and purified using reversed-phase chromatography to obtain white powdery cyclochrom-silk-valerine-isoleutin-leutin.
进一步限定的制备技术方案如下:The further limited preparation technical scheme is as follows:
所述蛙粪霉(Basidiobolussp.)为蛙生蛙粪霉、固孢蛙粪霉或裂孢蛙粪霉中的一种。The said Basidiobolus sp. is one of Basidiobolus sp., Basidiobolus sp., or Basidiobolus sp.
所述步骤(1)的具体操作如下:The specific operations of step (1) are as follows:
(1.1)斜面种子培养(1.1) Inclined seed culture
将蛙粪霉菌株接种于土豆琼脂(PDA)斜面培养基,于25~36℃恒温、培养4~8d,得到一级菌种;Inoculate the frog feces mold strain into potato agar (PDA) slant medium, culture it at a constant temperature of 25 to 36°C for 4 to 8 days, and obtain the first-level strain;
(1.2)二级菌种培养(1.2) Secondary strain culture
将一级菌种接种至液体摇瓶培养基培养;Inoculate the primary bacterial strain into the liquid shake flask culture medium;
在大于等于100 ml三角瓶中加入30~50%三角瓶体积的液体培养基,每个三角瓶接种1~3支斜面菌种,在全温振荡培养箱中,温度25~36℃、转速150~250 rpm条件下,培养3~7d,即得到二级菌种;Add 30 to 50% of the volume of the Erlenmeyer flask to a 100 ml Erlenmeyer flask. Inoculate 1 to 3 slant bacterial strains into each Erlenmeyer flask. In a full-temperature shaking incubator, the temperature is 25-36°C and the rotation speed is 150. Under the condition of ~250 rpm, cultivate for 3 to 7 days to obtain the secondary bacterial strain;
液体摇瓶培养基由葡萄糖25.0~50.0 g/L、麦芽提取物10.0~30.0 g/L、蛋白胨2.0~6.0 g/L、酵母浸出粉1.0~4.0 g/L、氯化钾(KCl2)0.3~2.0 g/L、七水硫酸镁(MgSO4.7H2O)0.3~2.0 g/L、磷酸二氢钾(KH2PO4)0.3~2.0 g/L;The liquid shake flask culture medium consists of glucose 25.0-50.0 g/L, malt extract 10.0-30.0 g/L, peptone 2.0-6.0 g/L, yeast extract powder 1.0-4.0 g/L, and potassium chloride (KCl 2 ) 0.3 ~2.0 g/L, magnesium sulfate heptahydrate (MgSO 4 .7H 2 O) 0.3 ~ 2.0 g/L, potassium dihydrogen phosphate (KH 2 PO 4 ) 0.3 ~ 2.0 g/L;
(1.3)三级菌种培养(1.3) Third-level bacterial culture
将二级菌种接种到大于等于5L的发酵罐,装液量为罐体积的50~80%,接种量3~10%,在通气量按体积比1:1~2(v/v)、压力0.1~0.2MP、25~36℃条件下,恒温通气培养2~5天,得到三级菌种;Inoculate the secondary bacteria into a fermentation tank larger than or equal to 5L. The liquid filling volume is 50-80% of the tank volume, the inoculation volume is 3-10%, and the ventilation volume is 1:1-2 (v/v), Under the conditions of pressure 0.1~0.2MP and 25~36℃, cultivate with constant temperature ventilation for 2~5 days to obtain the third-level bacterial strain;
发酵罐中的培养基同步骤(1.2)中的液体培养基;The culture medium in the fermentor is the same as the liquid culture medium in step (1.2);
(1.4)四级培养(1.4) Fourth-level training
四级培养为液体培养,将三级菌种接种到大于等于50L的发酵罐,装液量为罐体积的50~80%,接种量3~10%,在通气量按体积比1:1~2(v/v)、压力0.1~0.2MP、25~36℃条件下,恒温通气培养5~15天,得到液体的最终发酵物;发酵罐中的培养基步骤(1.2)中的液体培养基。The fourth-level culture is liquid culture. The third-level bacteria are inoculated into a fermentation tank of 50L or larger. The liquid volume is 50-80% of the tank volume, the inoculum volume is 3-10%, and the ventilation volume is 1:1~ 2 (v/v), pressure 0.1~0.2MP, 25~36℃, constant temperature ventilation culture for 5~15 days to obtain the final liquid fermentation product; the liquid culture medium in the culture medium step (1.2) in the fermentor .
所述步骤(1.4)中,四级培养为固体培养,将三级液体菌种拌入固体培养基中,接种量为固体料量的3~10%, 25~36℃恒温培养5~15天,得到固体的最终发酵物;所述固体培养基由葡萄糖25.0~50.0 g/L、麦芽提取物10.0~30.0 g/L、蛋白胨2.0~6.0 g/L、酵母浸出粉1.0~4.0 g/L、氯化钾(KCl2)0.3~2.0 g/L、七水硫酸镁(MgSO4.7H2O)0.3~2.0 g/L、磷酸二氢钾(KH2PO4)0.3~2.0 g/L、琼脂15.0~30.0 g/L和水混合均匀制成。In the step (1.4), the fourth-level culture is solid culture, and the third-level liquid strain is mixed into the solid culture medium. The inoculum amount is 3 to 10% of the solid material amount, and the culture is carried out at a constant temperature of 25 to 36°C for 5 to 15 days. , to obtain a solid final fermentation product; the solid culture medium consists of glucose 25.0-50.0 g/L, malt extract 10.0-30.0 g/L, peptone 2.0-6.0 g/L, yeast extract powder 1.0-4.0 g/L, Potassium chloride (KCl 2 ) 0.3~2.0 g/L, magnesium sulfate heptahydrate (MgSO 4 .7H 2 O) 0.3~2.0 g/L, potassium dihydrogen phosphate (KH 2 PO 4 ) 0.3~2.0 g/L, Made by mixing agar 15.0~30.0 g/L and water evenly.
所述步骤(2)的具体操作如下:The specific operations of step (2) are as follows:
(2.1)最终发酵物的预处理(2.1) Pretreatment of final fermentation product
将液体的最终发酵物经0.20~1.0μm滤膜过滤或2000-12000转/分钟条件下离心得到菌丝体;将菌丝体冷冻干燥,粉碎,得到过20~120目筛的预处理物;Filter the final fermentation product of the liquid through a 0.20-1.0 μm filter membrane or centrifuge at 2000-12000 rpm to obtain mycelium; freeze-dry the mycelium and crush it to obtain a pretreated product that passes through a 20-120 mesh sieve;
或,将固体的最终发酵物在30~130℃干燥到含水率小于等于20%,然后粉碎到20~120目的预处理物;Or, dry the solid final fermentation product at 30-130°C until the moisture content is less than or equal to 20%, and then crush it into a pre-processed product of 20-120 mesh;
(2.2)预处理物中有效成分的提取和分离纯化(2.2) Extraction, separation and purification of active ingredients in pretreatment materials
(2.2.1)提取(2.2.1) Extraction
将预处理物用甲醇或乙醇提取;料液比为1:2~20(W:V)、超声波功率10~100KHz,提取时间为10~200分钟;在转速大于等于2000转/分钟条件下离心,或0.20~1.0μm滤膜过滤;取滤液或离心上清,在温度小于等于100℃浓缩到原体积的1/2~1/10,得到浓缩脱醇液,同时回收甲醇或乙醇,浓缩脱醇液用于进一步的色谱法精制;Extract the pretreated material with methanol or ethanol; the material-liquid ratio is 1:2~20 (W:V), the ultrasonic power is 10~100KHz, the extraction time is 10~200 minutes; centrifuge at a speed of 2000 rpm or greater. , or 0.20~1.0μm filter membrane filtration; take the filtrate or centrifugal supernatant, and concentrate it to 1/2~1/10 of the original volume at a temperature of 100°C or less to obtain a concentrated dealcoholization liquid, while recovering methanol or ethanol, concentrating and de-alcoholizing. The alcohol liquid is used for further chromatographic purification;
(2.2.2)分离纯化(2.2.2) Separation and purification
采用反相色谱方法纯化,固定相为键合相填料,所述键合相填料为反相碳十八填料即RPC18,颗粒直径为3~50微米;用甲醇和水按0~100:100~0配比进行梯度洗脱,收集质谱检测器上分子量为676的色谱流份;将收集物在小于等于100℃温度以下浓缩到粘稠状,在低于170℃条件下干燥;得到白色粉末状的环色-丝-缬-异亮-亮肽。Reverse-phase chromatography is used for purification. The stationary phase is a bonded phase filler. The bonded phase filler is a reverse-phase carbon eighteen filler, that is, RPC18. The particle diameter is 3 to 50 microns; use methanol and water at a ratio of 0 to 100:100 to 0 ratio for gradient elution, collect the chromatographic fraction with a molecular weight of 676 on the mass spectrometer detector; concentrate the collection to a viscous state at a temperature of less than or equal to 100°C, and dry it at a temperature lower than 170°C; obtain a white powder The ring color-silk-valerian-isoleutin-leutin.
本发明的分析研究说明如下:The analytical research description of the present invention is as follows:
1、筛选研究发现一种蛙粪霉(Basidiobolussp.)菌丝甲醇提取物具有较强的清除自由基清活性和抗白色链珠菌活性:1. Screening research found that a methanol extract of Basidiobolus sp. mycelium has strong free radical scavenging activity and anti-Streptococcus albicans activity:
(1)甲醇提取物对白色链珠菌的抑制活性测定:配制提取物浓度为1.0 mg/ml 20%DMSO溶液,以两性霉素B为阳性对照,以20% DMSO溶液为空白对照,进行抑制白色链珠菌试验,经计算得出提取物对白色链珠菌的平均抑菌圈直径11.56 mm;(1) Determination of the inhibitory activity of methanol extract against Streptococcus albicans: Prepare an extract concentration of 1.0 mg/ml 20% DMSO solution, use amphotericin B as a positive control, and use 20% DMSO solution as a blank control for inhibition. In the Streptococcus albicans test, it was calculated that the average inhibition zone diameter of the extract against Streptococcus albicans was 11.56 mm;
(2)甲醇提取物的清除自由基活性测定: 配制提取物样品浓度为0.2、0.4、0.8、1.0、1.6 mg/ml甲醇溶液,于517 nm下测定其对0.5 mmol/L的DPPH自由基的清除活性,经计算得出其DPPH自由基的半数清除浓度 1.52 mg/mL。(2) Measurement of free radical scavenging activity of methanol extract: Prepare methanol solutions with extract sample concentrations of 0.2, 0.4, 0.8, 1.0, and 1.6 mg/ml, and measure its activity against 0.5 mmol/L DPPH free radical at 517 nm. Scavenging activity, the half scavenging concentration of DPPH free radicals was calculated to be 1.52 mg/mL.
由于甲醇提取物有效成分含量较低,因此需要进行有效成分的进一步提取和纯化。Since the content of active ingredients in the methanol extract is low, further extraction and purification of the active ingredients are required.
2、用反相色谱的方法对甲醇提取物进行了进一步分离纯化,得到一个纯品,其生物活性如下:2. The methanol extract was further separated and purified using reversed-phase chromatography to obtain a pure product with the following biological activities:
(1)环色-丝-缬-异亮-亮肽对白色链珠菌的抑制活性测定:配制提取物浓度为0.2mg/ml 20% DMSO溶液,以两性霉素B为阳性对照,以20% DMSO溶液为空白对照,进行抑制白色链珠菌试验,经计算得出提取物对白色链珠菌的平均抑菌圈直径13.27 mm;(1) Determination of the inhibitory activity of cyclochrome-silk-valerine-isoleukin-leupeptide against Streptococcus albicans: Prepare an extract concentration of 0.2 mg/ml 20% DMSO solution, use amphotericin B as a positive control, and use 20 % DMSO solution was used as a blank control to conduct an inhibition test against Streptococcus albicans. It was calculated that the average inhibition zone diameter of the extract against Streptococcus albicans was 13.27 mm;
(2)环色-丝-缬-异亮-亮肽的清除自由基活性测定: 配制提取物样品浓度为0.2、0.4、0.8、1.0、1.6 mg/ml甲醇溶液,于517 nm下测定其对0.5 mmol/L的DPPH自由基的清除活性,经计算得出其DPPH自由基的半数清除浓度 1.19 mg/mL。(2) Determination of free radical scavenging activity of cyclochrome-silk-valerine-isoleutin-leuptide: Prepare extract sample concentrations of 0.2, 0.4, 0.8, 1.0, 1.6 mg/ml methanol solution, and measure its effect on 517 nm The DPPH free radical scavenging activity of 0.5 mmol/L was calculated to have a half scavenging concentration of DPPH free radical of 1.19 mg/mL.
3、活性化合物的化学结构鉴定3. Identification of chemical structure of active compounds
高分辨液质联用分析显示纯化的活性化合物正离子585.3440(M+H+)、607.3261(M+Na+),623.3000(M+K+), 计算出的分子式为 C30H44N6O6。High-resolution liquid mass spectrometry analysis shows that the purified active compound has positive ions of 585.3440 (M+H + ), 607.3261 (M+Na + ), and 623.3000 (M+K + ). The calculated molecular formula is C 30 H 44 N 6 O 6 .
核磁共振分析数据见下表:The NMR analysis data are shown in the table below:
综合液质联用分析和核磁共振分析得出分离纯化出的活性化合物结构为环色-丝-缬-异亮-亮肽,见上述化学结构式。Comprehensive liquid mass spectrometry analysis and nuclear magnetic resonance analysis showed that the structure of the isolated and purified active compound is cyclochrom-silk-valerine-isoleutin-leuptide, as shown in the above chemical structural formula.
本发明的有益技术效果体现在下述几个方面:The beneficial technical effects of the present invention are reflected in the following aspects:
1、本发明方法制备的环色-丝-缬-异亮-亮肽具有抑制白色链珠菌和清除自由基活性,开拓了蛙粪霉的一个新的应用领域。本发明首次发现蛙粪霉具有代谢上述活性物质的功能。在此发明基础上可望进一步克隆出相关基因,构建高产量菌株。1. The cyclochromic-silk-valerian-isoleutin-leupeptide prepared by the method of the present invention has the activity of inhibiting Streptococcus albicans and scavenging free radicals, and opens up a new application field of A. faecalis. The present invention discovers for the first time that the fungus Frugospora has the function of metabolizing the above-mentioned active substances. Based on this invention, it is expected to further clone relevant genes and construct high-yield strains.
2、环色-丝-缬-异亮-亮肽是一新型骨架,可作为药物先导化合物进行衍生化改造,创造出活性更多更强的化合物。2. Cyclochrome-silk-valerine-isoleutin-leuptide is a new type of framework that can be used as a drug lead compound for derivatization to create more active compounds.
3、本发明的环色-丝-缬-异亮-亮肽可用于制备白色链珠菌抑制剂和自由基清除剂。自由基清除剂往往有增白、抗氧化、抗老化、保鲜、杀菌、消炎等作用,由环色-丝-缬-异亮-亮肽制备的白色链珠菌抑制剂可防治真菌感染。3. The cyclochromic-silk-valerian-isoleutin-leupeptide of the present invention can be used to prepare Streptococcus albicans inhibitors and free radical scavengers. Free radical scavengers often have the effects of whitening, antioxidant, anti-aging, preservation, sterilization, and anti-inflammatory. Streptococcus albicans inhibitors prepared from cyclochromic-silk-valerian-isoleutin-leuptide can prevent and treat fungal infections.
4、本发明由于采取微生物发酵生产,不受环境和资源影响,易实现工业化、自动化,不受环境和自然资源的影响。4. Since the present invention adopts microbial fermentation production, it is not affected by the environment and resources, and can easily realize industrialization and automation, and is not affected by the environment and natural resources.
5、按本发明工艺方法生产的产品成本低,工艺简便、工艺稳定、易调控、成功率高。5. The products produced according to the process of the present invention have low cost, simple process, stable process, easy control and high success rate.
具体实施方式Detailed ways
下面结合实施例,对本发明作进一步地描述。The present invention will be further described below in conjunction with examples.
实施例1:Example 1:
具有抗真菌和清除自由基活性的环色-丝-缬-异亮-亮肽的制备操作步骤如下:The preparation steps of cyclochrome-silk-valerine-isoleutin-leuptide with antifungal and free radical scavenging activity are as follows:
本实施例1所用的蛙粪霉为蛙生蛙粪霉。The fungus used in Example 1 is Frogspora frog.
(1)菌株培养(1) Strain culture
(1.1)斜面菌种培养(1.1) Slant culture
将蛙生蛙粪霉菌株接种于土豆琼脂(PDA)斜面培养基,于25℃恒温、培养4d,得到一级菌种;Inoculate the Frognata faecalis strain into potato agar (PDA) slant culture medium, culture it at a constant temperature of 25°C for 4 days, and obtain the first-level strain;
(1.2)二级菌种培养(1.2) Secondary strain culture
将一级菌种接种至液体摇瓶培养基培养;Inoculate the primary bacterial strain into the liquid shake flask culture medium;
液体摇瓶培养基:葡萄糖25.0g/L,麦芽提取物10.0g/L,蛋白胨2.0 g/L,酵母浸出粉1.0g/L,氯化钾(KCl2)0.3g/L,七水硫酸镁(MgSO4.7H2O)0.3g/L,磷酸二氢钾(KH2PO4)0.3g/L;Liquid shake flask culture medium: glucose 25.0g/L, malt extract 10.0g/L, peptone 2.0g/L, yeast extract powder 1.0g/L, potassium chloride (KCl 2 ) 0.3g/L, magnesium sulfate heptahydrate (MgSO 4 .7H 2 O) 0.3g/L, potassium dihydrogen phosphate (KH 2 PO 4 ) 0.3g/L;
在100 ml三角瓶中加入30%三角瓶体积的液体培养基,每个三角瓶接种1支斜面菌种,接种后置于全温振荡培养箱,温度25℃、转速150 rpm,培养3d,即得到二级菌种;Add 30% of the volume of the flask to a 100 ml Erlenmeyer flask. Inoculate 1 slant bacterial strain into each Erlenmeyer flask. After inoculation, place it in a full-temperature shaking incubator at a temperature of 25°C and a rotation speed of 150 rpm. Cultivate for 3 days, that is, Obtain secondary strains;
(1.3)三级菌种培养(1.3) Third-level bacterial culture
将二级菌种接种到5L的发酵罐,装液量为罐体积的50%,接种量3%,通气量按体积比1:1(v/v),压力0.1MP,25℃恒温通气培养2天,得到三级菌种;Inoculate the secondary bacteria into the 5L fermentation tank. The liquid volume is 50% of the tank volume, the inoculum volume is 3%, the ventilation volume is 1:1 (v/v), the pressure is 0.1MP, and the constant temperature ventilation culture is 25°C. In 2 days, third-level strains were obtained;
发酵罐中的培养基同液体摇瓶培养基。The culture medium in the fermentor is the same as the liquid shake flask culture medium.
(1.4)四级培养(1.4) Fourth-level training
四级培养采用液体培养:将三级菌种接种到50L的发酵罐,装液量为罐体积的50%,接种量3%,通气量按体积比1:1(v/v),压力0.1MP,25℃恒温通气培养5天,得到液体的最终发酵物;发酵罐中的培养基同液体摇瓶培养基;The fourth-level culture uses liquid culture: inoculate the third-level bacteria into a 50L fermentation tank, the liquid volume is 50% of the tank volume, the inoculum volume is 3%, the ventilation volume is 1:1 (v/v), and the pressure is 0.1 MP, culture at 25°C for 5 days with constant temperature ventilation to obtain the final liquid fermentation product; the culture medium in the fermentation tank is the same as the liquid shake flask culture medium;
(2)最终发酵物中有效成分的提取和精制(2) Extraction and purification of active ingredients in the final fermentation product
(2.1)最终发酵物的预处理(2.1) Pretreatment of final fermentation product
将液体的最终发酵物经0.20μm滤膜过滤得到菌丝体;将菌丝体冷冻干燥,粉碎到20目备用。The final fermentation product of the liquid was filtered through a 0.20 μm filter membrane to obtain mycelium; the mycelium was freeze-dried and crushed to 20 mesh for later use.
(2.2)提取(2.2) Extraction
将前述干燥菌丝,用甲醇提取;料液比为1:2(W:V)、超声波功率10KHz,提取时间为10分钟;提取结束后在转速2000转/分钟条件下离心,离心上清在温度100℃浓缩到原体积的1/2,得到浓缩脱醇液,同时回收甲醇,浓缩脱醇液用于进一步的色谱法精制。Extract the aforementioned dried mycelium with methanol; the material-to-liquid ratio is 1:2 (W:V), the ultrasonic power is 10KHz, and the extraction time is 10 minutes; after the extraction is completed, centrifuge at a speed of 2000 rpm, and the centrifugal supernatant is Concentrate to 1/2 of the original volume at a temperature of 100°C to obtain a concentrated dealcoholized liquid. Methanol is recovered at the same time, and the concentrated dealcoholized liquid is used for further chromatographic purification.
(2.3)分离纯化(2.3) Separation and purification
采用反相色谱方法纯化。固定相为键合相填料,所述键合相填料为反相碳十八填料即RPC18,颗粒直径为3微米,色谱柱直径和流动相流速可视生产规模来定;用乙醇或甲醇和水按0~100:100~0配比进行梯度洗脱,收集质谱检测器上分子量为676的目标峰;收集物在100℃温度以下浓缩到粘稠状,在170℃条件下干燥;得到白色粉末的环色-丝-缬-异亮-亮肽。Purified using reverse phase chromatography. The stationary phase is a bonded phase filler. The bonded phase filler is a reversed-phase carbon eighteen filler, that is, RPC18. The particle diameter is 3 microns. The diameter of the chromatographic column and the flow rate of the mobile phase can be determined according to the production scale; ethanol or methanol and water are used. Carry out gradient elution according to the ratio of 0~100:100~0, and collect the target peak with a molecular weight of 676 on the mass spectrometer detector; the collection is concentrated to a viscous state below 100°C, and dried at 170°C; a white powder is obtained The ring color-silk-valerian-isoleutin-leutin.
结构鉴定结果显示环色-丝-缬-异亮-亮肽的结构式如下:The structural identification results show that the structural formula of cyclochrome-silk-valerine-isoleutin-leuptide is as follows:
活性测定结果显示,环色-丝-缬-异亮-亮肽对二苯基苦基苯肼自由基(DPPH)的半数清除浓度(DC50)为:1.19 mg/mL;在200 μg /mL的浓度下对白色链珠菌的抑菌圈直径为13.27 mm。The activity measurement results show that the half scavenging concentration (DC 50 ) of cyclochrome-silk-valerine-isoleutin-leuptide on diphenylpicrylphenylhydrazine free radical (DPPH) is: 1.19 mg/mL; at 200 μg/mL The diameter of the inhibition zone against Streptococcus albicans is 13.27 mm.
实施例2Example 2
具有抗真菌和清除自由基活性的环色-丝-缬-异亮-亮肽的制备操作步骤如下:The preparation steps of cyclochrome-silk-valerine-isoleutin-leuptide with antifungal and free radical scavenging activity are as follows:
本实施例2所用的蛙粪霉为裂孢蛙粪霉。The fungus used in Example 2 is Frogspora.
(1)菌株培养(1) Strain culture
(1.1)斜面菌种培养(1.1) Slant culture
将裂孢蛙粪霉菌株接种于土豆琼脂(PDA)斜面培养基,于36℃恒温、培养8d,得到一级菌种;Inoculate the Schizospermum faecalis strain into potato agar (PDA) slant culture medium, culture it at a constant temperature of 36°C for 8 days, and obtain the first-level strain;
(1.2)二级菌种培养(1.2) Secondary strain culture
将一级菌种接种至液体摇瓶培养基培养;Inoculate the primary bacterial strain into the liquid shake flask culture medium;
液体摇瓶培养基:葡萄糖50.0 g/L,麦芽提取物30.0 g/L,蛋白胨6.0 g/L,酵母浸出粉4.0 g/L,氯化钾(KCl2)0.3g/L,七水硫酸镁(MgSO4.7H2O) 0.3g/L,磷酸二氢钾(KH2PO4)2.0 g/L。Liquid shake flask medium: glucose 50.0 g/L, malt extract 30.0 g/L, peptone 6.0 g/L, yeast extract powder 4.0 g/L, potassium chloride (KCl 2 ) 0.3 g/L, magnesium sulfate heptahydrate (MgSO 4 .7H 2 O) 0.3g/L, potassium dihydrogen phosphate (KH 2 PO 4 ) 2.0 g/L.
在1000 ml三角瓶中加入50%三角瓶体积的液体培养基,每个三角瓶接种3支斜面菌种,接种后置于全温振荡培养箱,温度36℃、转速250 rpm,培养7d,即得到二级菌种。Add 50% of the volume of the flask to a 1000 ml Erlenmeyer flask. Inoculate 3 strains of slant bacteria into each Erlenmeyer flask. After inoculation, place it in a full-temperature shaking incubator at a temperature of 36°C and a rotation speed of 250 rpm. Cultivate for 7 days, that is, Obtain secondary strains.
(1.3)三级菌种培养(1.3) Third-level bacterial culture
将二级菌种接种50L的发酵罐,装液量为罐体积的80%,接种量10%,通气量按体积比1:2(v/v),压力0.2MP,36℃恒温通气培养5天,得到三级菌种。Inoculate the secondary bacterial strain into a 50L fermentation tank. The liquid volume is 80% of the tank volume, the inoculum volume is 10%, the ventilation volume is 1:2 (v/v), the pressure is 0.2MP, and the constant temperature ventilation culture is 36°C for 5 Days later, a third-level bacterial strain was obtained.
发酵罐中的培养基同液体摇瓶培养基。The culture medium in the fermentor is the same as the liquid shake flask culture medium.
(1.4)四级培养(1.4) Fourth-level training
四级培养为液体培养:将三级菌种接种到大于等于500L的发酵罐,装液量为罐体积的80%,接种量10%,通气量按体积比1:2(v/v),压力0.2MP,36℃恒温通气培养15天,得到液体的最终发酵物;发酵罐中的培养基同液体摇瓶培养基。The fourth-level culture is liquid culture: inoculate the third-level bacteria into a fermentation tank larger than or equal to 500L. The liquid volume is 80% of the tank volume, the inoculum volume is 10%, and the aeration volume is based on the volume ratio of 1:2 (v/v). Pressure 0.2MP, constant temperature ventilation culture at 36°C for 15 days to obtain the final liquid fermentation product; the culture medium in the fermentation tank is the same as the liquid shake flask culture medium.
(2)最终发酵物中有效成分的提取和精制(2) Extraction and purification of active ingredients in the final fermentation product
(2.1)最终发酵物的预处理(2.1) Pretreatment of final fermentation product
将液体的最终发酵物经1.0μm滤膜过滤得到菌丝体;将菌丝体冷冻干燥,粉碎到120目备用。The final fermentation product of the liquid was filtered through a 1.0 μm filter membrane to obtain mycelium; the mycelium was freeze-dried and crushed to 120 mesh for later use.
(2.2)提取(2.2) Extraction
将前述干燥菌丝用乙醇提取,料液比为1:20(W:V)、超声波功率100KHz,提取时间为200分钟;提取结束后在转速12000转/分钟条件下离心,离心上清在温度40℃浓缩到原体积的1/10,得到浓缩脱醇液,同时回收乙醇,浓缩脱醇液用于进一步的色谱法精制。Extract the aforementioned dried mycelium with ethanol, with a solid-liquid ratio of 1:20 (W:V), an ultrasonic power of 100KHz, and an extraction time of 200 minutes; after the extraction, centrifuge at a speed of 12,000 rpm, and the centrifugal supernatant is at a temperature of Concentrate to 1/10 of the original volume at 40°C to obtain a concentrated dealcoholized liquid. At the same time, ethanol is recovered, and the concentrated dealcoholized liquid is used for further chromatographic purification.
(2.3)分离纯化(2.3) Separation and purification
采用反相色谱方法纯化。固定相为键合相填料,所述键合相填料为反相碳十八填料即RPC18,颗粒直径为50微米,色谱柱直径和流动相流速可视生产规模来定;用甲醇和水按0~100:100~0配比进行梯度洗脱,收集质谱检测器上分子量为676的目标峰;收集物在30℃温度以下浓缩到粘稠状,在-30℃条件下干燥;得到白色粉末状的环色-丝-缬-异亮-亮肽。Purified using reverse phase chromatography. The stationary phase is a bonded phase filler. The bonded phase filler is a reversed phase carbon eighteen filler, that is, RPC18. The particle diameter is 50 microns. The diameter of the chromatographic column and the flow rate of the mobile phase can be determined according to the production scale; use methanol and water at 0 Perform gradient elution with a ratio of ~100:100~0, and collect the target peak with a molecular weight of 676 on the mass spectrometer detector; the collection is concentrated to a viscous state below 30°C, and dried at -30°C; a white powder is obtained The ring color-silk-valerian-isoleutin-leutin.
结构鉴定结果显示,环色-丝-缬-异亮-亮肽的结构式如下:Structural identification results show that the structural formula of cyclochrome-silk-valerine-isoleutin-leuptide is as follows:
活性测定结果显示,环色-丝-缬-异亮-亮肽对二苯基苦基苯肼自由基(DPPH)的半数清除浓度(DC50)为:1.19 mg/mL;在200 μg /mL的浓度下对白色链珠菌的抑菌圈直径为13.27 mm。The activity measurement results show that the half scavenging concentration (DC 50 ) of cyclochrome-silk-valerine-isoleutin-leuptide on diphenylpicrylphenylhydrazine free radical (DPPH) is: 1.19 mg/mL; at 200 μg/mL The diameter of the inhibition zone against Streptococcus albicans is 13.27 mm.
实施例3Example 3
具有抗真菌和清除自由基活性的环色-丝-缬-异亮-亮肽的制备操作步骤如下:The preparation steps of cyclochrome-silk-valerine-isoleutin-leuptide with antifungal and free radical scavenging activity are as follows:
本实施例3所选用的菌种为固孢蛙粪霉。The bacterial strain selected in Example 3 is Bacterosporum faecalis.
(1)菌株培养(1) Strain culture
(1.1)斜面菌种培养(1.1) Slant culture
将固孢蛙粪霉菌株接种于土豆琼脂(PDA)斜面培养基,于30℃恒温、培养6d,得到一级菌种;Inoculate the Apodophora faecalis strain into potato agar (PDA) slant culture medium, culture it at a constant temperature of 30°C for 6 days, and obtain the first-level strain;
(1.2)二级菌种培养(1.2) Secondary strain culture
将一级菌种接种至液体摇瓶培养基培养;Inoculate the primary bacterial strain into the liquid shake flask culture medium;
液体摇瓶培养基:葡萄糖35.0 g/L,麦芽提取物20.0 g/L,蛋白胨4.0 g/L,酵母浸出粉2.0 g/L,氯化钾(KCl2)0.3g/L,七水硫酸镁(MgSO4.7H2O)0.3g/L,磷酸二氢钾(KH2PO4)1.0 g/L。Liquid shake flask medium: glucose 35.0 g/L, malt extract 20.0 g/L, peptone 4.0 g/L, yeast extract powder 2.0 g/L, potassium chloride (KCl 2 ) 0.3 g/L, magnesium sulfate heptahydrate (MgSO 4 .7H 2 O) 0.3g/L, potassium dihydrogen phosphate (KH 2 PO 4 ) 1.0 g/L.
在500 ml三角瓶中加入40%三角瓶体积的液体培养基,每个三角瓶接种2支斜面菌种,接种后置于全温振荡培养箱,温度30℃、转速200 rpm,培养5d,即得到二级菌种。Add 40% of the volume of the Erlenmeyer flask to a 500 ml Erlenmeyer flask. Inoculate 2 strains of slant bacteria into each Erlenmeyer flask. After inoculation, place it in a full-temperature shaking incubator at a temperature of 30°C and a rotation speed of 200 rpm. Cultivate for 5 days, that is, Obtain secondary strains.
(1.3)三级菌种培养(1.3) Third-level bacterial culture
将二级菌种接种到50L的发酵罐,装液量为罐体积的60%,接种量6%,通气量按体积比1:1.5(v/v),压力0.15MP,30℃恒温通气培养3天,得到三级菌种。Inoculate the secondary bacterial strain into a 50L fermentation tank. The liquid volume is 60% of the tank volume, the inoculum volume is 6%, the ventilation volume is 1:1.5 (v/v), the pressure is 0.15MP, and the constant temperature ventilation culture is 30°C. In 3 days, the third-level bacteria were obtained.
发酵罐中的培养基同液体摇瓶培养基。The culture medium in the fermentor is the same as the liquid shake flask culture medium.
(1.4)四级培养(1.4) Fourth-level training
四级培养为固体培养:将三级液体菌种拌入固体培养基中,接种量为固体料量的3%,25℃恒温通气培养10天,得到固体的最终发酵物;所述固体培养基为:葡萄糖25.0 g/L,麦芽提取物10.0 g/L,蛋白胨2.0 g/L,酵母浸出粉1.0 g/L,氯化钾(KCl2)0.3g/L,七水硫酸镁(MgSO4.7H2O)0.3g/L,磷酸二氢钾(KH2PO4)0.3 g/L;琼脂15.0 g/L。The fourth-level culture is solid culture: mix the third-level liquid strain into the solid culture medium, the inoculum amount is 3% of the solid material amount, and culture it at 25°C for 10 days with constant temperature ventilation to obtain a solid final fermentation product; the solid culture medium It is: glucose 25.0 g/L, malt extract 10.0 g/L, peptone 2.0 g/L, yeast extract powder 1.0 g/L, potassium chloride (KCl 2 ) 0.3 g/L, magnesium sulfate heptahydrate (MgSO 4 . 7H 2 O) 0.3g/L, potassium dihydrogen phosphate (KH 2 PO 4 ) 0.3 g/L; agar 15.0 g/L.
(2)最终发酵物中有效成分的提取和精制(2) Extraction and purification of active ingredients in the final fermentation product
(2.1)最终发酵物的预处理(2.1) Pretreatment of final fermentation product
将固体的最终发酵物在30℃干燥到含水率等于20%,然后粉碎到20目备用。The solid final fermentation product is dried at 30°C until the moisture content is equal to 20%, and then crushed to 20 mesh for later use.
(2.2)提取(2.2) Extraction
将干燥粉碎的最终发酵物用乙醇提取;料液比为1:2(W:V)、超声波功率10KHz,提取时间为10分钟;提取结束后用0.20μm滤膜过滤;滤液在温度30℃浓缩到原体积的1/2,得到浓缩脱醇液,同时回收乙醇,浓缩脱醇液用于进一步的色谱法精制;Extract the dried and crushed final fermentation product with ethanol; the material-to-liquid ratio is 1:2 (W:V), the ultrasonic power is 10KHz, and the extraction time is 10 minutes; after the extraction is completed, it is filtered with a 0.20μm filter membrane; the filtrate is concentrated at a temperature of 30°C To 1/2 of the original volume, a concentrated dealcoholization liquid is obtained, ethanol is recovered at the same time, and the concentrated dealcoholization liquid is used for further chromatographic purification;
(2.3)分离纯化(2.3) Separation and purification
采用反相色谱方法纯化。固定相为键合相填料,所述键合相填料为反相碳十八填料即RPC18,颗粒直径为25微米,色谱柱直径和流动相流速可视生产规模来定;用甲醇和水按0~100:100~0配比进行梯度洗脱,收集质谱检测器上分子量为676的目标峰;收集物在40℃温度以下浓缩到粘稠状,在10℃条件下干燥;得到白色粉末状的环色-丝-缬-异亮-亮肽。Purified using reverse phase chromatography. The stationary phase is a bonded phase filler. The bonded phase filler is a reversed-phase carbon eighteen filler, that is, RPC18. The particle diameter is 25 microns. The diameter of the chromatographic column and the flow rate of the mobile phase can be determined according to the production scale; use methanol and water at 0 ~100:100~0 ratio for gradient elution, and the target peak with a molecular weight of 676 on the mass spectrometer detector was collected; the collection was concentrated to a viscous state below 40°C, and dried at 10°C; a white powder was obtained. Ring color - silk - valerian - different bright - leukopeptide.
结构鉴定结果显示,环色-丝-缬-异亮-亮肽的结构式如下:Structural identification results show that the structural formula of cyclochrome-silk-valerine-isoleutin-leuptide is as follows:
活性测定结果显示,环色-丝-缬-异亮-亮肽对二苯基苦基苯肼自由基(DPPH)的半数清除浓度(DC50)为:1.19 mg/mL;在200 μg /mL的浓度下对白色链珠菌的抑菌圈直径为13.27 mm。The activity measurement results show that the half scavenging concentration (DC 50 ) of cyclochrome-silk-valerine-isoleutin-leuptide on diphenylpicrylphenylhydrazine free radical (DPPH) is: 1.19 mg/mL; at 200 μg/mL The diameter of the inhibition zone against Streptococcus albicans is 13.27 mm.
实施例4:Example 4:
具有抗真菌和清除自由基活性的环色-丝-缬-异亮-亮肽的制备操作步骤如下:The preparation steps of cyclochrome-silk-valerine-isoleutin-leuptide with antifungal and free radical scavenging activity are as follows:
本实施例4所用的蛙粪霉蛙生蛙粪霉。The frog used in Example 4 is called Frogfae.
(1)菌株培养(1) Strain culture
培养方法为液体固体混合培养,具体工序如下:The culture method is liquid-solid mixed culture, and the specific procedures are as follows:
(1.1)斜面菌种培养(1.1) Slant culture
将保藏的蛙粪霉菌株接种于土豆琼脂(PDA)斜面培养基,于29℃恒温、培养5d,得到一级菌种;The preserved frog feces mold strain was inoculated into potato agar (PDA) slant culture medium, and cultured at a constant temperature of 29°C for 5 days to obtain the first-level strain;
(1.2)二级菌种培养(1.2) Secondary strain culture
将一级菌种接种至液体摇瓶培养基培养;Inoculate the primary bacterial strain into the liquid shake flask culture medium;
液体摇瓶培养基:葡萄糖40.0 g/L,麦芽提取物25.0 g/L,蛋白胨3.0 g/L,酵母浸出粉3.0 g/L,氯化钾(KCl2)0.3g/L,七水硫酸镁(MgSO4.7H2O)0.3g/L,磷酸二氢钾(KH2PO4)1.2 g/L。Liquid shake flask culture medium: glucose 40.0 g/L, malt extract 25.0 g/L, peptone 3.0 g/L, yeast extract powder 3.0 g/L, potassium chloride (KCl 2 ) 0.3 g/L, magnesium sulfate heptahydrate (MgSO 4 .7H 2 O) 0.3g/L, potassium dihydrogen phosphate (KH 2 PO 4 ) 1.2 g/L.
在500 ml三角瓶中加入40%三角瓶体积的液体培养基,每个三角瓶接种1支斜面菌种,接种后置于全温振荡培养箱,温度30℃、转速180 rpm,培养4d,即得到二级菌种。Add 40% of the volume of the flask to a 500 ml Erlenmeyer flask. Inoculate 1 slant bacterial strain into each Erlenmeyer flask. After inoculation, place it in a full-temperature shaking incubator at a temperature of 30°C and a rotation speed of 180 rpm. Cultivate for 4 days, that is, Obtain secondary strains.
(1.3)三级菌种培养(1.3) Third-level bacterial culture
将二级菌种接种到30L的发酵罐,装液量为罐体积的65%,接种量6%,通气量按体积比1:1.2(v/v),压力0.12MP,32℃恒温通气培养3天,得到三级菌种。Inoculate the secondary bacteria into a 30L fermentation tank. The liquid volume is 65% of the tank volume, the inoculum volume is 6%, the ventilation volume is 1:1.2 (v/v), the pressure is 0.12MP, and the constant temperature ventilation culture is 32°C. In 3 days, the third-level bacteria were obtained.
发酵罐中的培养基同液体摇瓶培养基。The culture medium in the fermentor is the same as the liquid shake flask culture medium.
(1.4)四级培养(1.4) Fourth-level training
四级培养采用固体培养:将三级液体菌种拌入固体培养基中,接种量为固体料量的10%,36℃恒温通气培养8天,得到固体的最终发酵物;The fourth-level culture adopts solid culture: mix the third-level liquid strain into the solid culture medium, the inoculum amount is 10% of the solid material amount, and cultivate it for 8 days at 36°C with constant temperature ventilation to obtain the solid final fermentation product;
固体培养基为:葡萄糖50.0 g/L,麦芽提取物30.0 g/L,蛋白胨6.0 g/L,酵母浸出粉4.0 g/L,氯化钾(KCl2)0.3g/L,七水硫酸镁(MgSO4.7H2O)0.3g/L,磷酸二氢钾(KH2PO4)2.0g/L,琼脂30.0 g/L。The solid culture medium is: glucose 50.0 g/L, malt extract 30.0 g/L, peptone 6.0 g/L, yeast extract powder 4.0 g/L, potassium chloride (KCl 2 ) 0.3 g/L, magnesium sulfate heptahydrate ( MgSO 4 .7H 2 O) 0.3g/L, potassium dihydrogen phosphate (KH 2 PO 4 ) 2.0g/L, agar 30.0 g/L.
(2)最终发酵物中有效成分的提取和精制(2) Extraction and purification of active ingredients in the final fermentation product
(2.1)最终发酵物的预处理(2.1) Pretreatment of final fermentation product
将固体的最终发酵物在130℃干燥到含水率10%,然后粉碎到120目备用。The solid final fermentation product was dried at 130°C to a moisture content of 10%, and then crushed to 120 mesh for later use.
(2.2)提取(2.2) Extraction
将干燥粉碎的最终发酵物用甲醇提取,料液比为1:20(W:V)、超声波功率100KHz,提取时间为200分钟;提取结束后在用1.0μm滤膜过滤;滤液在40℃浓缩到原体积的1/10,得到浓缩脱醇液,同时回收甲醇,浓缩脱醇液用于进一步的色谱法精制;Extract the dried and crushed final fermentation product with methanol. The material-to-liquid ratio is 1:20 (W:V), the ultrasonic power is 100KHz, and the extraction time is 200 minutes. After the extraction, it is filtered with a 1.0 μm filter membrane; the filtrate is concentrated at 40°C. To 1/10 of the original volume, a concentrated dealcoholization liquid is obtained, while methanol is recovered, and the concentrated dealcoholization liquid is used for further chromatographic purification;
(2.3)分离纯化(2.3) Separation and purification
采用反相色谱方法纯化。固定相为键合相填料,所述键合相填料为反相碳十八填料即RPC18,颗粒直径为10微米,色谱柱直径和流动相流速可视生产规模来定;用甲醇和水按0~100:100~0配比进行梯度洗脱,收集质谱检测器上分子量为676的目标峰;收集物在100℃温度以下浓缩到粘稠状,在170℃条件下干燥;得到白色粉末状的环色-丝-缬-异亮-亮肽。Purified using reverse phase chromatography. The stationary phase is a bonded phase filler. The bonded phase filler is a reversed-phase carbon eighteen filler, that is, RPC18. The particle diameter is 10 microns. The diameter of the chromatographic column and the flow rate of the mobile phase can be determined according to the production scale; use methanol and water at 0 ~100:100~0 ratio for gradient elution, and the target peak with a molecular weight of 676 on the mass spectrometer detector was collected; the collection was concentrated to a viscous state below 100°C, and dried at 170°C; a white powder was obtained. Ring color - silk - valerian - different bright - leukopeptide.
结构鉴定结果显示,环色-丝-缬-异亮-亮肽的结构式如下:Structural identification results show that the structural formula of cyclochrome-silk-valerine-isoleutin-leuptide is as follows:
活性测定结果显示,环色-丝-缬-异亮-亮肽对二苯基苦基苯肼自由基(DPPH)的半数清除浓度(DC50)为:1.19 mg/mL;在200 μg /mL的浓度下对白色链珠菌的抑菌圈直径为13.27 mm。The activity measurement results show that the half scavenging concentration (DC 50 ) of cyclochrome-silk-valerine-isoleutin-leuptide on diphenylpicrylphenylhydrazine free radical (DPPH) is: 1.19 mg/mL; at 200 μg/mL The diameter of the inhibition zone against Streptococcus albicans is 13.27 mm.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110602791.5A CN113307848B (en) | 2021-05-31 | 2021-05-31 | Cyclochrome-silk-valerian-isoleukin-leupeptide with antifungal and free radical scavenging activity and preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110602791.5A CN113307848B (en) | 2021-05-31 | 2021-05-31 | Cyclochrome-silk-valerian-isoleukin-leupeptide with antifungal and free radical scavenging activity and preparation method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113307848A CN113307848A (en) | 2021-08-27 |
CN113307848B true CN113307848B (en) | 2023-11-17 |
Family
ID=77376574
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110602791.5A Active CN113307848B (en) | 2021-05-31 | 2021-05-31 | Cyclochrome-silk-valerian-isoleukin-leupeptide with antifungal and free radical scavenging activity and preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113307848B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113583094A (en) * | 2021-09-09 | 2021-11-02 | 皖北卫生职业学院 | Cyclo-valine-silk-isoleucin-leucin with antifungal and free radical scavenging activities and preparation method thereof |
CN115651067B (en) * | 2022-11-24 | 2024-04-30 | 安徽农业大学 | Cyclic color-propyl-valyl-isoleucyl-leucinide with hepatoma cytotoxicity and alpha-glucosidase inhibitory activity and preparation method thereof |
CN116023443B (en) * | 2022-11-24 | 2024-04-30 | 安徽农业大学 | Cyclochrom-silver-valerian-leucine-leucine peptide with hepatoma cell toxicity and α-glucosidase inhibitory activity and preparation method thereof |
CN115636869B (en) * | 2022-11-24 | 2024-04-30 | 安徽农业大学 | Cyclosporine isoleucine peptide having liver cancer cell toxicity and α-glucosidase inhibitory activity and preparation method thereof |
CN115572324B (en) * | 2022-11-24 | 2024-04-30 | 安徽农业大学 | Cyclic color-valyl-leu-phenylpropanoid with hepatoma cytotoxicity and alpha-glucosidase inhibitory activity and preparation method thereof |
CN115651068B (en) * | 2022-11-24 | 2024-04-30 | 安徽农业大学 | Cyclic color-propyl-casein-isopropyl-phenyl propyl peptide with hepatoma cytotoxicity and alpha-glucosidase inhibitory activity and preparation method thereof |
CN115651069B (en) * | 2022-11-24 | 2024-04-30 | 安徽农业大学 | Cyclic color-threo-tyr-valyl-phenylpropanoid with hepatoma cytotoxicity and alpha-glucosidase inhibitory activity and preparation method thereof |
CN115636871B (en) * | 2022-11-24 | 2024-04-30 | 安徽农业大学 | Cyclic color-threo-tyrosol-isoleucyl-phenylpropanoid with hepatoma cytotoxicity and alpha-glucosidase inhibitory activity and preparation method thereof |
CN115716864B (en) * | 2022-11-24 | 2024-04-30 | 安徽农业大学 | Cyclic color-valyl-leucinyl peptide with hepatoma cytotoxicity and alpha-glucosidase inhibitory activity and preparation method thereof |
CN115636870B (en) * | 2022-11-24 | 2024-04-30 | 安徽农业大学 | Cyclic color-threo-valyl-leucinyl peptide with hepatoma cytotoxicity and alpha-glucosidase inhibitory activity and preparation method thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006108215A1 (en) * | 2005-04-15 | 2006-10-19 | Charles Sturt University | Anti-fungal treatments |
CN101389642A (en) * | 2005-12-22 | 2009-03-18 | 诺瓦生命科学有限公司 | Cyclic antimicrobial peptides |
CN103360486A (en) * | 2004-08-18 | 2013-10-23 | 诺瓦生命科学有限公司 | Antimicrobial peptides comprising arginine-and/or lysine-containing motif |
CN107236757A (en) * | 2016-03-28 | 2017-10-10 | 中国科学院天津工业生物技术研究所 | A kind of method for improving the expression of filamentous fungi lignocellulosic enzyme system and biological-based chemicals production |
CN111018954A (en) * | 2020-01-19 | 2020-04-17 | 安徽农业大学 | Cyclo-serine-valine-leucine peptide with antifungal and free radical scavenging activities and preparation method thereof |
-
2021
- 2021-05-31 CN CN202110602791.5A patent/CN113307848B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103360486A (en) * | 2004-08-18 | 2013-10-23 | 诺瓦生命科学有限公司 | Antimicrobial peptides comprising arginine-and/or lysine-containing motif |
WO2006108215A1 (en) * | 2005-04-15 | 2006-10-19 | Charles Sturt University | Anti-fungal treatments |
CN101389642A (en) * | 2005-12-22 | 2009-03-18 | 诺瓦生命科学有限公司 | Cyclic antimicrobial peptides |
CN107236757A (en) * | 2016-03-28 | 2017-10-10 | 中国科学院天津工业生物技术研究所 | A kind of method for improving the expression of filamentous fungi lignocellulosic enzyme system and biological-based chemicals production |
CN111018954A (en) * | 2020-01-19 | 2020-04-17 | 安徽农业大学 | Cyclo-serine-valine-leucine peptide with antifungal and free radical scavenging activities and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
灰色变异链霉菌抗菌肽的分离及鉴定;秦小萍 等;《农药》;第47卷(第11期);第805-806、809页 * |
Also Published As
Publication number | Publication date |
---|---|
CN113307848A (en) | 2021-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113307848B (en) | Cyclochrome-silk-valerian-isoleukin-leupeptide with antifungal and free radical scavenging activity and preparation method | |
CN113264987B (en) | Cyclochrome-threo-valerine-isoleutin-leupeptide with antifungal and free radical scavenging activity and preparation method thereof | |
CN111018953B (en) | Cyclocasein-isoleucyl-leucyl-tryptophyl-threo-peptide with antifungal and free radical scavenging activities and preparation method thereof | |
CN111018954B (en) | Cyclo-serine-valine-leucine peptide with antifungal and free radical scavenging activities and preparation method thereof | |
CN101186932B (en) | Method for synchronously producing hypocrellin and shiraia bambusicola polysaccharides | |
CN113583094A (en) | Cyclo-valine-silk-isoleucin-leucin with antifungal and free radical scavenging activities and preparation method thereof | |
CN103655215B (en) | Paecilomyces extract with tyrosinase inhibitory activity and free radical scavenging activity and use thereof | |
CN106086147A (en) | Fungal elicitor is utilized to induce the method extracting betulic acid from Inonqqus obliquus | |
CN118421745B (en) | Application of Enterococcus monteri in producing dihydroouabain | |
CN104004692B (en) | A kind of bacillus subtilis and the application of earthy in controlling Chinese liquor thereof | |
CN115651067B (en) | Cyclic color-propyl-valyl-isoleucyl-leucinide with hepatoma cytotoxicity and alpha-glucosidase inhibitory activity and preparation method thereof | |
CN104278070B (en) | Method for improving content of ergosterol in liquid fermentation products of phellinus igniarius | |
CN104004693B (en) | A kind of Bacillus pumilus and the application of earthy in controlling Chinese liquor thereof | |
CN1177925C (en) | Fermenting culture process of produicng Cordyceps extract | |
CN110540952B (en) | Lutein-producing prokaryotic microorganism and its application in the production of lutein | |
CN115636869B (en) | Cyclosporine isoleucine peptide having liver cancer cell toxicity and α-glucosidase inhibitory activity and preparation method thereof | |
CN115716865B (en) | Cyclic color-threo-tyr-valyl-leupeptin with hepatoma cytotoxicity and alpha-glucosidase inhibition activity and preparation method thereof | |
CN115651068B (en) | Cyclic color-propyl-casein-isopropyl-phenyl propyl peptide with hepatoma cytotoxicity and alpha-glucosidase inhibitory activity and preparation method thereof | |
CN115716864B (en) | Cyclic color-valyl-leucinyl peptide with hepatoma cytotoxicity and alpha-glucosidase inhibitory activity and preparation method thereof | |
CN115572324B (en) | Cyclic color-valyl-leu-phenylpropanoid with hepatoma cytotoxicity and alpha-glucosidase inhibitory activity and preparation method thereof | |
CN114315936A (en) | N6-ethyl acetate-5'-acetyl-β-riboadenosine with inhibiting pancreatic lipase activity and preparation method | |
CN115636870B (en) | Cyclic color-threo-valyl-leucinyl peptide with hepatoma cytotoxicity and alpha-glucosidase inhibitory activity and preparation method thereof | |
CN115536734B (en) | Cyclochrom-pro-valpro-leu-leu-leu peptide with liver cancer cell toxicity and alpha-glucosidase inhibitory activity and preparation method thereof | |
CN116023443B (en) | Cyclochrom-silver-valerian-leucine-leucine peptide with hepatoma cell toxicity and α-glucosidase inhibitory activity and preparation method thereof | |
CN115636871B (en) | Cyclic color-threo-tyrosol-isoleucyl-phenylpropanoid with hepatoma cytotoxicity and alpha-glucosidase inhibitory activity and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |